Grupo Circuito Goiano

The Fetal Bovine Serum Market is experiencing significant growth, driven by advancements in biotechnology and pharmaceutical research. Fetal bovine serum (FBS) is a crucial component in cell culture media, supporting the growth and maintenance of cells for various applications, including vaccine production, drug discovery, and regenerative medicine.

In 2024, the global market was valued at approximately USD 1.02 billion and is projected to reach USD 1.07 billion in 2025, reflecting a compound annual growth rate (CAGR) of 5.6% . By 2029, the market is expected to expand further to USD 1.34 billion, growing at a CAGR of 5.7% .